Baring Asset Management’s Pfizer PFE Stock Holding History

Baring Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$572K	Sell	16,896 -24,620	-59%	-$791K	0.03%	158
2017 Q2	$1.32M	Hold	41,516	–	–	0.09%	126
2017 Q1	$1.35M	Sell	41,516 -61,654	-60%	-$1.94M	0.09%	132
2016 Q4	$3.18M	Buy	103,170 +2,970	+3%	+$90.7K	0.22%	85
2016 Q3	$3.22M	Sell	100,200 -13,295	-12%	-$445K	0.23%	84
2016 Q2	$3.79M	Hold	113,495	–	–	0.31%	77
2016 Q1	$3.19M	Sell	113,495 -19,394	-15%	-$554K	0.27%	74
2015 Q4	$4.07M	Buy	132,889 +3,720	+3%	+$117K	0.35%	72
2015 Q3	$3.85M	Buy	129,169 +22,548	+21%	+$723K	0.35%	74
2015 Q2	$3.39M	Sell	106,621 -1,399	-1%	-$45.6K	0.28%	79
2015 Q1	$3.56M	Sell	108,020 -229,363	-68%	-$7.29M	0.28%	73
2014 Q4	$9.97M	Sell	337,383 -56,558	-14%	-$1.62M	0.63%	59
2014 Q3	$11.1M	Buy	+393,941	New	+$11.1M	0.65%	54

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Baring Asset Management's PFE Position: Q3 2017 in Review

Baring Asset Management reduced its Pfizer (PFE) stake by 59% in Q3 2017, selling an estimated $791K and leaving 16,896 shares worth $572K. The position accounts for 0.03% of the portfolio, ranked #158.

Baring Asset Management first reported a position in PFE in Q3 2014 and has held it in 13 quarters since. The position peaked at $11.1M in Q3 2014. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Baring Asset Management held 16,896 shares of Pfizer worth $572K as of Q3 2017.
Baring Asset Management sold 24,620 Pfizer shares in Q3 2017, an estimated $791K.
Pfizer made up 0.03% of Baring Asset Management's portfolio in Q3 2017, its #158 holding.
Baring Asset Management first reported a position in Pfizer in Q3 2014 and has held it in 13 quarters since.
Baring Asset Management's Pfizer position peaked at $11.1M in Q3 2014.
2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.